Integrated Care and Treatment-Resistant Depression
Closing thoughts regarding a discussion on improving the management of patients with treatment-resistant depression using newer treatment approaches in a more standardized fashion.
Electroconvulsive Therapy for Depression
Insight regarding proper timing to initiate electroconvulsive therapy to help manage depression.
Traditional Classes of Antidepressant Therapies
Dr Patricia Ares-Romero highlights the traditional classes of antidepressant therapies available, reacts to common treatment-related adverse events, and describes when each type of therapy is most appropriate within a patient’s treatment course.
Frontline Psychotherapy for Depression
The appropriateness for initiating psychotherapy, either alone or in combination with other therapies, as frontline treatment for depression.
Treatment-Resistant Depression: Financial Support for Esketamine Therapy
Recommendations that can help clinicians navigate through the reimbursement process and best support patients who receive intranasal esketamine for treatment-resistant depression.
Incorporating Esketamine into Practice for Treatment-Resistant Depression
Additional variables that require consideration if treating appropriate patients with treatment-resistant depression with intranasal esketamine within certified treatment facilities.
Getting Certified to Administer Esketamine for Treatment-Resistant Depression
Requirements that healthcare clinics must satisfy to become a certified treatment center permitted to administer intranasal esketamine to patients with treatment-resistant depression.
Treatment-Resistant Depression: Administering Esketamine to Patients
Best practices that can be applied when working with patients and training staff on proper ways to administer intranasal esketamine therapy for treatment-resistant depression in a supervised medical setting.
REMS Safety Program for Esketamine in Treatment-Resistant Depression
The purpose and impact of the REMS program established to support the integration of intranasal esketamine into clinics that manage treatment-resistant depression.
Response to Esketamine Therapy for Treatment-Resistant Depression
Practical experience regarding the timing and response to intranasal esketamine therapy for treatment-resistant depression.
Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression
Strategies that can be used to monitor patients on intranasal esketamine therapy for treatment-resistant depression, with special considerations surrounding blood pressure management.
Esketamine for Treatment-Resistant Depression: Patient Selection Criteria
Criteria that can be used to help determine who may or may not be appropriate for intranasal esketamine therapy for treatment-resistant depression.
Intranasal Esketamine for Treatment-Resistant Depression
A description regarding the mechanism of action of intranasal esketamine, a newer therapy for treatment-resistant depression, and current opportunities for use over other treatment options.
Current Guidelines for Managing Treatment-Resistant Depression
An overview of what is currently recommended by the APA guidelines for the management of treatment-resistant depression, with insight regarding topics that need to be revisited and addressed further to help standardize care for patients.
IV Ketamine for Treatment-Resistant Depression
The rationale for treating treatment-resistant depression and other psychiatric conditions with off-label intravenous ketamine.
Prevalence of Treatment-Resistant Depression
Dr Angelos Halaris provides clarity to the definition of treatment-resistant depression and suggests what may contribute to high prevalence rates.
Looking Back: A Lesson from the Loss of Robin Williams
A reflection on the fallout from the untimely passing of a beloved celebrity, and what our reactions tell us about how we view depression and suicide.
The Downside of More Effective, Fast-acting Antidepressants
Even a "magic bullet" leaves a wound that requires a period of recovery.
When Risk-taking in Psychiatry Is Tested
In this particular age of the Internet and social media, losing a lawsuit is not the only thing that can damage a physician's career.
Growing Awareness for Ketamine Treatment in Depression and Anxiety
When I first considered intravenous ketamine to treat severely treatment-resistant depression 4 years ago, I was in a scary, lonely place where I received a lot of skeptical questions and funny looks accompanying chirping crickets.
The Neurobiological Driver of Cravings for Dirt and Other Drugs
What do you crave: food, material possessions, love, attention, sex, sugar, chocolate, drugs, alcohol, praise, or power? For hundreds of thousands of people around the world, the answer is dirt.
Psychiatrists Are Setting an Unhealthy Example
With mounting evidence in support of long-suspected mind-body connections, psychiatrists must consider physical activity as both prevention and treatment.
A Psychiatrist's Parody of Mental Health Parity
There has been much speculation about whether the implementation of complex mental health parity rules will actually yield equal coverage of care.
How to Talk About God in Psychotherapy
The effective therapist will practice what he preaches, pun intended.
Can Cough Medicine Treat Depression?
One treatment-resistant depression patient's response to over-the-counter cough medicine led Steven P. Levine, MD, to study the mechanism and effects of dextromethorphan in depression.
Talking About Poop for Mental Illness with a Straight Face
Steven P. Levine, MD, says the implications of altering the microbiome may extend beyond C. difficile to mental health, given the new insight into the connection between the gut and mind.
Do No Harm, Unless Doing No Harm Hurts
Steven P. Levine, MD, reminds prescribers to satisfy the voices in their heads by acknowledging that any medicine may be poisonous to patients.
A Two-Column Approach to Depression and Anxiety Treatment
Steven P. Levine, MD, recommends selecting a biologic intervention from column A and a psychotherapy agent from column B to effectively treat depression and anxiety.
Looking Back at Ketamine Delivers New Results in Treatment-Resistant Depression
Steven P. Levine, MD, says new research on an old medicine has injected excitement into major depressive disorder treatment.
2 Clarke Drive Cranbury, NJ 08512